These changes suggested reduced capacity of CP to maintain CSF T4 homeostasis, and could also reduce chelation of beta-amyloid, which may result in an added risk for Alzheimer's disease in patients experiencing similar changes in TTR synthesis. The gene discussed is TTR; the disease is Alzheimer disease.